La cadena de opciones muestra datos clave de las opciones de acciones de Plus Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Plus Therapeutics..

Plus Therapeutics (NASDAQ:PSTV) Bolsa, Cadena de Opciones

Plus Therapeutics

Plus Therapeutics Inc

POSTAL SVGS CHINA UNS/ADR by Postal Svgs Bk of China Ltd.

Postal Savings Bank Of China Co Ltd

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Aligos Therapeutics

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Annovis Bio

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

CervoMed

Cue Biopharma

CEL-SCI

Evaxion

FibroGen

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

MiNK Therapeutics

IO Biotech

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Medicus Pharma

OS Therapies

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

Skye Bioscience

Senti Biosciences

TScan Therapeutics

Plus Therapeutics (PSTV) Previsión

Noticias

Beneficios

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Comments

Plus Therapeutics Cadena de Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL